ubmslatePT-logo-ubm

PT Mobile Logo

Topics:

Psychopharmacology

APA 2015

Check here for all of our APA 2015 coverage or visit one of our topic-specific pages:

APA: Bipolar Disorder
APA: Major Depressive Disorder
APA: Schizophrenia

Psychopharmacology

Recent data show that widespread discrepancy exists between clinical guidelines and practice patterns for ADHD, dementia, and bipolar disorders.

Are you up-to-date on the risk of recurrent pneumonia in patients with schizophrenia when an antipsychotic is reintroduced?

Three new studies show the effects of depression—and its treatment—on the brain.

This method of administration can mitigate the psychotomimetic and dissociative effects of ketamine.

lassedesignen/Shutterstock

New evidence—coupled with advances in molecular biology—has afforded an unparalleled opportunity to move toward identifying potential new treatments for schizophrenia.

How do the 3 FDA-approved dopamine receptor partial agonists for the treatment of MDD and other psychiatric disorders stack up against each other?

A new finding that may help optimize the treatment of major depressive disorder.

Pages

Subscribe to Psychopharmacology on [sitename]

CME Center

Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.

By clicking Accept, you agree to become a member of the UBM Medica Community.